ASPG and pancreatitis: Moreover, the GDP regimen (gemcitabine, dexamethasone, and cisplatin) had equally superior efficacy and reduced toxicity, including a lower incidence of myelosuppression, prolonged activated partial thromboplastin time, pancreatitis, and anaphylactic reaction, in comparison to L-asparaginase treatment (54).